Stay updated on Pembrolizumab with Radiotherapy in CTCL Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page.

Latest updates to the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedNIH grant/contract information was added to the study identifiers. The site revision was updated to v3.6.6 and the previous revision v3.6.5 was removed.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision label updated from v3.6.4 to v3.6.5, indicating a minor update to the underlying platform.SummaryDifference0.0%

- Check39 days agoChange DetectedThe study's results status label changed from 'No Results Posted' to 'Results Submitted', indicating that the trial's results have been submitted for reporting and are awaiting posting.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page's revision label updated from v3.6.3 to v3.6.4. This indicates a new build of the page without affecting the study data or displayed content.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page footer now shows Revision: v3.6.3, indicating a platform update that affects the interface but not the clinical trial details.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page shows a revision stamp update from v3.6.0 to v3.6.2, indicating a small deployment update.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Radiotherapy in CTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page.